Sover. Diamonds (523826)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 2/2 · Dividend: 0/1

Key Financials

Strengths

• Trades at P/B of 0.97, slightly below book value of ₹30.88 per share
• Piotroski F-Score of 6/9 indicates moderate balance-sheet health, not deeply distressed
• Positive ROCE of 5% shows the operations still generate some return on capital employed

Concerns

• Sales growth of -74.53% and latest quarter sales of just ₹3 Cr signal a severe demand collapse
• ROE of -26.60% means shareholder capital is being eroded
• P/E of 0.00 and net profit of ₹0 Cr mean there is no current earnings yield; the 300% profit growth is misleading from a near-zero base
• Promoter holding and debt/equity are N/A, leaving critical governance and leverage questions unanswered

AI Analysis

At ₹29.95, Sover. Diamonds carries a market cap of just ₹17 Cr, while book value stands at ₹30.88 per share. So I am being asked to pay roughly 97 paise for every rupee of stated net assets. That sounds like Graham's asset approach, but the first rule is to confirm the asset is productive. This business is not. Return on equity is -26.60%, meaning equity is being consumed, not created. The latest quarter shows sales of only ₹3 Cr and net profit of ₹0 Cr. A headline profit growth of 300% is worthless when the starting base is near zero. Full-year sales have collapsed by 74.53%, so there is no evidence of durable demand. ROCE of 5% is positive but too thin for the risks in gems, jewellery, and inventory. There is no dividend, no promoter holding data, and no debt-equity ratio disclosed; too many blanks for a careful investor. The Piotroski F-Score of 6 out of 9 suggests some balance-sheet stability, but that is not enough. In this industry, book value can erode quickly if stock or receivables become unsaleable. A small discount to book is not a margin of safety if the asset base is impaired. I would need to see sales stabilise, management give honest accounts, and a clear path to positive sustainable profits. Until then, this is a situation to watch, not a compounder to buy. Patience is part of the art.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer